학술논문
5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)
Document Type
Abstract
Author
Source
In Clinical Lymphoma Myeloma and Leukemia October 2011 11 Supplement 2:S273-S275
Subject
Language
ISSN
2152-2650